Patent details

EP2036549 Title: Novel Composition

Basic Information

Publication number:
EP2036549
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP081668816
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Novel Composition
French Title of Invention:
Nouvelle composition
German Title of Invention:
Neuartige Zusammensetzung
SPC Number:

Dates

Filing date:
29/01/2003
Grant date:
07/04/2010
EP Publication Date:
07/04/2010
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/03/2009
EP B1 Publication Date:
07/04/2010
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
29/01/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/01/2003
 
 

Name:
AstraZeneca AB
Address:
-, 151 85 Södertälje, Sweden (SE)

Agent

Name:
VAN MALDEREN JOELLE
From:
06/07/2010
Address:
ROUTE D'ARLON 261, 8002, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Marlow Maria
Address:
United Kingdom (GB)

2

Name:
Govind Nayna
Address:
United Kingdom (GB)

Priority

Priority Number:
0200312
Priority Date:
01/02/2002
Priority Country:
Sweden (SE)

Classification

Main IPC Class:
A61K 31/167;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
10/01/2022
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages